Department of Biochemistry and Biophysics and Cystic Fibrosis Center, University of North Carolina, Chapel Hill, NC 27599, USA.
FASEB J. 2010 Aug;24(8):3103-12. doi: 10.1096/fj.09-141788. Epub 2010 Mar 16.
Deletion of PHE508 (DeltaF508) from the first nucleotide-binding domain (NBD1) of CFTR, which causes most cystic fibrosis, disrupts the folding and assembly of the protein. Although the folding pathways and yield of isolated NBD1 are altered, its global structure is not, and details of the changes in the rest of the protein remain unclear. To gain further insight into how the whole mutant protein is altered, we have determined the influence of known second-site suppressor mutations in NBD1 on the conformation of this domain and key interfaces between domains. We found that the suppressors restored maturation of only those processing mutations located in NBD1, but not in other domains, including those in the C-terminal cytoplasmic loop of the second membrane-spanning domain, which forms an interface with the NBD1 surface. Nevertheless, the suppressors promoted the formation of this interface and others in the absence of F508. The suppressors restored maturation in a DeltaF508 construct from which NBD2 was absent but to a lesser extent than in the full-length, indicating that DeltaF508 disrupts interactions involving NBD2, as well as other domains. Rescue of DeltaF508-CFTR by suppressors required the biosynthesis of the entire full-length protein in continuity, as it did not occur when N- and C-terminal "halves" were coexpressed. Simultaneous with these interdomain perturbations, DeltaF508 resulted in suppressor reversed alterations in accessibility of residues both in the F508-containing NBD1 surface loop and in the Q loop within the domain core. Thus, in the context of the full-length protein, DeltaF508 mutation causes detectable changes in NBD1 conformation, as well as interdomain interactions.
CFTR 中第一个核苷酸结合域(NBD1)中 PHE508(DeltaF508)的缺失导致了大多数囊性纤维化,破坏了蛋白质的折叠和组装。尽管分离的 NBD1 的折叠途径和产量发生了改变,但它的整体结构没有改变,蛋白质其余部分的变化细节仍不清楚。为了更深入地了解整个突变蛋白是如何改变的,我们确定了 NBD1 中已知的第二位置抑制突变对该结构域和结构域之间关键界面的构象的影响。我们发现,这些抑制剂仅能恢复那些位于 NBD1 中的加工突变的成熟,而不是其他结构域中的突变,包括第二跨膜结构域的 C 端细胞质环中的突变,该结构域与 NBD1 表面形成界面。然而,在没有 F508 的情况下,抑制剂促进了该界面和其他界面的形成。抑制剂在 NBD2 缺失的 DeltaF508 构建体中恢复了成熟度,但不如全长构建体中恢复的程度大,这表明 DeltaF508 破坏了涉及 NBD2 和其他结构域的相互作用。抑制剂对 DeltaF508-CFTR 的挽救需要整个全长蛋白质的连续生物合成,因为当 N 端和 C 端“半”同时表达时,这种挽救就不会发生。在这些结构域间干扰的同时,DeltaF508 导致 F508 所在的 NBD1 表面环和结构域核心内的 Q 环中的残基的可及性发生了抑制剂逆转的改变。因此,在全长蛋白质的背景下,DeltaF508 突变导致 NBD1 构象以及结构域间相互作用发生了可检测的变化。